FrancophonIA/ELRC3.0 huggingface dataset:
English: If you have kidney problems your doctor may lower your dose.
Croatian: Ako imate bubrežnih tegoba, liječnik će Vam možda smanjiti dozu.
English: The total time interval between starting reconstitution and completing preparation of the intravenous infusion should not exceed 30 minutes.
Croatian: Ukupno vrijeme od početka rekonstitucije do završetka pripreme intravenske infuzije ne smije biti dulje od 30 minuta.
English: Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Croatian: Preosjetljivost na djelatne tvari ili neku od pomoćnih tvari navedenih u dijelu 6.1.
English: Zavicefta will be given to you by a doctor or a nurse.
Croatian: Lijek Zavicefta će Vam dati Vaš liječnik ili medicinska sestra.
English: If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8ºC, unless reconstitution/dilution has taken place in controlled and validated aseptic conditions.
Croatian: Ako se ne primijeni odmah, vrijeme i uvjeti čuvanja do primjene lijeka odgovornost su korisnika i ne bi smjelo biti dulje od 24 sata na temperaturi od 2 do 8°C, osim ako rekonstitucija/razrjeđivanje nisu provedeni u kontroliranim i validiranim aseptičkim uvjetima.
English: The maximum recommended daily dose of this medicinal product contains 444 mg sodium (found in table salt).
Croatian: Maksimalna preporučena dnevna doza ovog lijeka sadrži 444 mg natrija (glavni sastojak kuhinjske soli).
English: This is equivalent to 22.2% of the adult recommended maximum daily dietary intake for sodium.
Croatian: To odgovara 22,2% preporučenog maksimalnog dnevnog unosa soli za odraslu osobu.
English: Pharmacokinetic/pharmacodynamic relationship
Croatian: Farmakokinetički/farmakodinamički odnos
English: Pharmacotherapeutic group: Antibacterials for systemic use, ceftazidime, combinations, ATC code: J01DD52
Croatian: Farmakoterapijska skupina: Lijekovi za liječenje bakterijskih infekcija za sustavnu primjenu, ceftazidim, kombinacije, ATK oznaka: J01DD52
English: In the rat, no adverse effects were observed on embryofetal development or fertility.
Croatian: Kod štakora nisu primijećeni štetni učinci na embriofetalni razvoj ni plodnost.
English: Frequency categories are derived from adverse reactions and/or potentially clinically significant laboratory abnormalities, and are defined according to the following conventions:
Croatian: Kategorije učestalosti temelje se na nuspojavama i/ili potencijalno klinički značajnim laboratorijskim odstupanjima, a definiraju se na sljedeći način:
English: This could cause symptoms such as fits (see section If you use more
Croatian: To može dovesti do simptoma poput napadaja (vidjeti dio Ako primijenite više lijeka Zavicefta nego što ste trebali)
English: 5-10 days
Croatian: 5 - 10 dana
English: The safety assessment in children is based on the safety data from 1 trial in which 61 paediatric patients aged from 3 years to less than 18 years with cIAI received Zavicefta.
Croatian: Procjena sigurnosti primjene u djece temelji se na podacima o sigurnosti primjene dobivenim tijekom 1 ispitivanja u kojem je 61 pedijatrijski bolesnik, u dobi od 3 godine do manje od 18 godina, s kompliciranom intraabdominalnom infekcijom primao lijek Zavicefta.
English: Volume of diluent to be added (mL)
Croatian: Volumen otapala koji se dodaje (ml)
English: The total inuse stability from reconstitution to administration should not exceed 36 hours (24 hours at 2-8°C plus 12 hours room temperature).
Croatian: Ukupno vrijeme čuvanja od rekonstitucije do primjene ne smije biti dulje od 36 sati (24 sata na temperaturi od 2 do 8 °C plus 12 sati na sobnoj temperaturi).
English: • redness, pain or swelling where Zavicefta was given into a vein
Croatian: • crvenilo, bol ili oticanje na mjestu gdje je Zavicefta primijenjena u venu
English: 2 hours Guided by the severity of the infection, the pathogen(s) and the patient's clinical and bacteriological progress
Croatian: 2 sata Sukladno težini infekcije, patogenu(ima) te bolesnikovu kliničkom i bakteriološkom napretku
English: Transfer the entire contents (approximately 12.0 mL) of the resultant solution to an infusion bag immediately.
Croatian: 4. Odmah prenesite sav sadržaj (približno 12,0 ml) dobivene otopine u infuzijsku vrećicu.
English: Gram-negative micro-organisms
Croatian: Gram-negativni mikroorganizmi
English: • Avibactam is a “beta-lactamase inhibitor” that helps ceftazidime kill some bacteria that it cannot kill on its own.
Croatian: • Avibaktam je "inhibitor beta-laktamaza" koji pomaže ceftazidimu uništiti neke bakterije koje ceftazidim ne može uništiti sam.
English: The resulting solution should be administered over 120 minutes.
Croatian: Dobivenu otopinu treba primijeniti tijekom 120 minuta.
English: A white to yellow powder.
Croatian: Prašak bijele do žute boje.
English: A decision must be made whether to discontinue breast feeding or to discontinue/abstain from ceftazidime/avibactam therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Croatian: Potrebno je odlučiti da li prekinuti dojenje ili prekinuti liječenje/suzdržati se od liječenja ceftazidimom/avibaktamom uzimajući u obzir korist dojenja za dijete i korist liječenja za ženu.
English: • a type of antibiotic called an aminoglycoside - such as gentamicin, tobramycin
Croatian: • vrstu antibiotika koja se zove aminoglikozid - poput gentamicina, tobramicina
English: Total volume
Croatian: Ukupan volumen
English: The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the marketing authorisation and any agreed subsequent updates of the RMP.
Croatian: Nositelj odobrenja obavljat će zadane farmakovigilancijske aktivnosti i intervencije, detaljno objašnjene u dogovorenom Planu upravljanja rizikom (RMP), koji se nalazi u Modulu 1.8.2 Odobrenja za stavljanje lijeka u promet, te svim sljedećim dogovorenim ažuriranim verzijama RMP-a.
English: After reconstitution, 1 mL of solution contains 167.3 mg of ceftazidime and 41.8 mg of avibactam (see section 6.6).
Croatian: Nakon rekonstitucije, 1 ml otopine sadrži 167,3 mg ceftazidima i 41,8 mg avibaktama (vidjeti dio 6.6).
English: Tell the person taking the sample that you have been given Zavicefta.
Croatian: Recite osobi koja uzima uzorak da ste primili lijek Zavicefta.
English: Ceftazidime is not metabolised.
Croatian: Ceftazidim se ne metabolizira.
English: • an infection of the lungs called “pneumonia”
Croatian: • infekcije pluća koja se zove "pneumonija"
English: Keep this leaflet.
Croatian: - Sačuvajte ovu uputu.
English: • Staphylococcus aureus (methicillin-susceptible and methicillin-reistant)
Croatian: • Staphylococcus aureus (osjetljivog na meticilin i rezistentnog na meticilin)
English: The clinical relevance of this finding is unknown, but due to the possibility of antagonism in vivo this drug combination should be avoided.
Croatian: Iako klinički značaj ovog nalaza nije poznat, navedenu kombinaciju lijekova treba izbjegavati zbog mogućih antagonističkih učinaka in vivo.
English: The European Medicines Agency has deferred the obligation to submit the results of studies with Zavicefta in one or more subsets of the paediatric population in the treatment of intra-abdominal infections, urinary tract infections, pneumonia and Gram-negative bacterial infections (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove odgodila je obvezu podnošenja rezultata ispitivanja lijeka Zavicefta u jednoj ili više podskupina pedijatrijske populacije u liječenju intraabdominalnih infekcija, infekcija mokraćnog sustava, pneumonije i Gram-negativnih bakterijskih infekcija (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: Zavicefta is indicated for the treatment of the following infections in adults (see sections 4.4 and 5.1):
Croatian: Zavicefta je indicirana u odraslih za liječenje sljedećih infekcija (vidjeti dijelove 4.4 i 5.1):
English: Probenecid (a potent OAT inhibitor) inhibits this uptake by 56% to 70% in vitro and, therefore, has the potential to alter the elimination of avibactam.
Croatian: Probenecid (potentan inhibitor prijenosnika OAT) in vitro inhibira to preuzimanje za 56% do 70% te stoga može izmijeniti eliminaciju avibaktama.
English: The medicinal product is supplied in packs of 10 vials.
Croatian: Lijek je dostupan u pakiranjima od 10 bočica.
English: • diarrhoea that keeps getting worse or does not go away, or stools that contains blood or mucus this may happen during or after treatment is stopped with Zavicefta.
Croatian: • proljev koji se neprekidno pogoršava ili ne prolazi ili stolica koja sadrži krv ili sluz - to se može javiti tijekom liječenja lijekom Zavicefta ili nakon njega.
English: 7-14 days
Croatian: 7 - 14 dana
English: Overall, the safety profile in these 61 children was similar to that observed in the adult population with cIAI.
Croatian: Sveukupno, sigurnosni profil lijeka u navedenog 61 djeteta bio je sličan sigurnosnom profilu lijeka koji je zabilježen u odrasloj populaciji s kompliciranom intraabdominalnom infekcijom.
English: Any unused product or waste material should be disposed of in accordance with local requirements.
Croatian: Neiskorišteni lijek ili otpadni materijal potrebno je zbrinuti sukladno nacionalnim propisima.
English: After reconstitution
Croatian: Nakon rekonstitucije:
English: In vitro, avibactam is a substrate of OAT1 and OAT3 transporters which might contribute to the active uptake of avibactam from the blood compartment and therefore affect its excretion.
Croatian: In vitro je avibaktam supstrat prijenosnika OAT1 i OAT3, koji bi mogli pridonositi aktivnom preuzimanju avibaktama iz krvnog odjeljka i time utjecati na njegovo izlučivanje.
English: • Ceftazidime belongs to the group of antibiotics called “cephalosporins”.
Croatian: • Ceftazidim pripada skupini antibiotika koji se zovu "cefalosporini".
English: Death occurred in 2.1% (18/857) of patients who received Zavicefta and metronidazole and in 1.4% (12/863) of patients who received meropenem.
Croatian: Smrt je nastupila u 2,1% (18/857) bolesnika koji su primali lijek Zaviceftu i metronidazol i u 1,4% (12/863) bolesnika koji su primali meropenem.
English: • a medicine for gout called probenecid
Croatian: • lijek za giht koji se zove probenecid
English: Do not use this medicine after the expiry date which is stated on the container.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na spremniku.
English: Approximately 87% of patients had APACHE II scores of ≤ 10 and 4.0% had bacteraemia at baseline.
Croatian: Otprilike 87% bolesnika imalo je APACHE II rezultat ≤ 10, a 4,0% bolesnika imalo je bakterijemiju na početku ispitivanja.
English: This may affect you being able to drive, use tools or machines.
Croatian: Ona može utjecati na Vašu sposobnost upravljanja vozilima, rukovanja alatima ili rada sa strojevima.
English: Reduced doses may be achieved by transfer of an appropriate volume of the resultant solution to an infusion bag, based upon ceftazidime and avibactam content of 167.3 mg/mL and 41.8 mg/mL, respectively.
Croatian: Manje doze mogu se postići prijenosom odgovarajućeg volumena dobivene otopine u infuzijsku vrećicu, izračunatog na temelju sadržaja ceftazidima od 167,3 mg/ml i avibaktama od 41,8 mg/ml.
English: Hypersensitivity reactions
Croatian: Reakcije preosjetljivosti
English: The chemical and physical in-use stability has been demonstrated for up to 24 hours at 2 - 8°C, followed by up to 12 hours at not more than 25
Croatian: Kemijska i fizikalna stabilnost za vrijeme uporabe dokazana je tijekom najviše 24 sata na temperaturi od 2 do 8°C i nakon toga do najviše 12 sati na temperaturi koja ne smije biti viša od 25°C.
English: Ceftazidime is excreted in human milk in small quantities.
Croatian: Ceftazidim se izlučuje u majčino mlijeko u malim količinama.
English: Following administration of avibactam throughout pregnancy and lactation in the rat, there was no effect on pup survival, growth or development, however there was an increase in incidence of dilation of the renal pelvis and ureters in less than 10% of the rat pups at maternal exposures greater than or equal to approximately 1.5 times human therapeutic exposures.
Croatian: Nakon primjene avibaktama ženkama štakora tijekom cijelog razdoblja skotnosti i laktacije, nije primijećen učinak na preživljenje, rast i razvoj mladunčadi, ali je kod manje od 10% mladunaca zabilježena povećana incidencija dilatacije bubrežnog pelvisa i uretera pri razinama izloženosti majke koje su bile približno 1,5 ili više puta veće od terapijske izloženosti kod ljudi.
English: • you have ever had any allergic reaction (even if only a skin rash) to other antibiotics belonging to the penicillin or carbapenem groups
Croatian: • ako ste ikada imali bilo kakvu alergijsku reakciju (čak i samo kožni osip) na druge antibiotike koji pripadaju skupini penicilina ili karbapenema
English: The most common adverse reactions occurring in ≥ 5% of patients treated with Zavicefta were Coombs direct test positive, nausea, and diarrhoea.
Croatian: Najčešće nuspojave, koje su se javile kod ≥ 5% bolesnika liječenih lijekom Zavicefta, bile su pozitivan nalaz direktnog Coombsovog testa, mučnina i proljev.
English: For instructions on reconstitution and dilution of the medicinal product before administration see section 6.6.
Croatian: Za upute o rekonstituciji i razrjeđivanju lijeka prije primjene vidjeti dio 6.6.
English: Before beginning treatment, it should be established whether the patient has a history of hypersensitivity reactions to ceftazidime, to other cephalosporins or to any other type of β-lactam antibacterial agent.
Croatian: Prije početka liječenja potrebno je ustanoviti ima li bolesnik u anamnezi reakcije preosjetljivosti na ceftazidim, druge cefalosporine ili bilo koju drugu vrstu beta-laktamskih antibakterijskih lijekova.
English: Ceftazidime may interfere with copper reduction methods (Benedict's, Fehling's, Clinitest) for detection of glycosuria leading to false positive results.
Croatian: Ceftazidim može utjecati na metode redukcije bakra (Benedictova reakcija, Fehlingova reakcija, Clinitest) za detektiranje glikozurije, što dovodi do lažno pozitivnih nalaza.
English: GlaxoSmithKline Manufacturing S.p.A VIA A. FLEMING, 2
Croatian: GlaxoSmithKline Manufacturing S.p.A. Via Alessandro Fleming 2
English: Excipient with known effect: each vial contains 6.44 mmol of sodium (approximately 148 mg).
Croatian: Pomoćna tvar s poznatim učinkom: jedna bočica sadrži 6,44 mmol natrija (približno 148 mg).
English: Ceftazidime has little or no activity against the majority of Gram-positive organisms and anaerobes (see sections 4.2 and 5.1).
Croatian: Ceftazidim malo utječe ili ne utječe na većinu Gram-pozitivnih organizama i anaeroba (vidjeti dijelove 4.2 i 5.1).
English: Powder for concentrate for solution for infusion (powder for concentrate).
Croatian: Prašak za koncentrat za otopinu za infuziju (prašak za koncentrat).
English: While DAGT seroconversion in patients receiving Zavicefta was very common in clinical studies (the estimated range of seroconversion across Phase 3 studies was 3.2% to 20.8% in patients with a negative Coombs test at baseline and at least one followup test), there was no evidence of haemolysis in patients who developed a positive DAGT on treatment.
Croatian: Iako je serokonverzija dokazana DAGT-om u bolesnika koji su primali lijek Zavicefta bila vrlo česta u kliničkim ispitivanjima (procijenjeni raspon serokonverzije u ispitivanjima faze 3 bio je 3,2% do 20,8% u bolesnika s negativnim Coombsovim testom na početku i na najmanje jednom kontrolnom testom), nije bilo dokaza hemolize u bolesnika u kojih se tijekom liječenja razvio pozitivan nalaz DAGT-a.
English: Additional antibacterial agents should be used when these pathogens are known or suspected to be contributing to the infectious process.
Croatian: Dodatne antibakterijske lijekove potrebno je primjenjivati kada je potvrđeno ili se sumnja da navedeni patogeni pridonose razvoju infekcije.
English: GlaxoSmithKline Manufacturing S.p.A.
Croatian: GlaxoSmithKline Manufacturing S.p.A VIA A.
English: The human protein binding of both ceftazidime and avibactam is approximately 10% and 8%, respectively.
Croatian: Vezanje i ceftazidima i avibaktama za proteine u ljudi iznosi otprilike 10% odnosno 8%.
English: Plasma exposure levels at maternal and foetal NOAEL (100 mg/kg/day) indicate moderate to low margins of safety.
Croatian: NOAEL) za majku i fetus (100 mg/kg/dan) ukazuju na umjerene do niske sigurnosne granice.
English: These include thrush (fungal infections of the mouth or genital area).
Croatian: To uključuje i gljivičnu infekciju kandidom (gljivične infekcije usta i genitalnog područja).
English: The following adverse reactions have been reported with ceftazidime alone and/or identified during the Phase 2 and Phase 3 trials with Zavicefta.
Croatian: Sljedeće nuspojave prijavljene su kod primjene samo ceftazidima i/ili su utvrđene tijekom primjene lijeka Zavicefta u kliničkim ispitivanjima faze 2 i faze 3.
English: Ceftazidime
Croatian: Ceftazidim
English: Pfizer Ireland Pharmaceuticals Operations Support Group Ringaskiddy, County Cork Ireland
Croatian: Pfizer Ireland Pharmaceuticals Operations Support Group Ringaskiddy, County Cork Irska
English: Avibactam penetration of the blood brain barrier has not been studied clinically; however, in rabbits with inflamed meninges, CSF exposures of ceftazidime and avibactam were 43% and 38% of plasma AUC, respectively.
Croatian: Prodiranje avibaktama kroz krvno-moždanu barijeru nije se klinički ispitivalo; međutim, kod kunića s upaljenim moždanim ovojnicama, izloženost ceftazidimu i avibaktamu u cerebrospinalnom likvoru iznosila je 43% odnosno 38% plazmatskog AUC-a.
English: Non-susceptible organisms
Croatian: Neosjetljivi organizmi
English: Animal studies with ceftazidime do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development.
Croatian: Ispitivanja ceftazidima na životinjama ne ukazuju na izravan ili neizravan štetan učinak na trudnoću, razvoj embrija/fetusa, okot ni postnatalni razvoj.
English: It inhibits both Ambler class A and class C β-lactamases and some class D enzymes, including extended-spectrum β-lactamases (ESBLs), KPC and OXA-48 carbapenemases, and AmpC enzymes.
Croatian: Inhibira beta-laktamaze Ambler klase A i klase C te neke enzime klase D, uključujući beta-laktamaze proširenog spektra (engl. extended-spectrum β-lactamases, ESBL), KPC i OXA-48 karbapenemaze, te AmpC enzime.
English: Penetration of ceftazidime into the intact blood-brain barrier is poor.
Croatian: Prodiranje ceftazidima u neoštećenu krvno-moždanu barijeru je neznatno.
English: Serum levels of ceftazidime can be reduced by haemodialysis or peritoneal dialysis.
Croatian: Serumske vrijednosti ceftazidima mogu se sniziti hemodijalizom ili peritonejskom dijalizom.
English: Ceftazidime inhibits bacterial peptidoglycan cell wall synthesis following binding to penicillin binding proteins (PBPs), which leads to bacterial cell lysis and death.
Croatian: Ceftazidim inhibira sintezu bakterijske peptidoglikanske stanične stijenke nakon vezanja za proteine koji vežu penicilin (engl. penicillin binding proteins, PBP), što dovodi do lize i smrti bakterijske stanice.
English: If you have too much Zavicefta it could have an effect on the brain and cause fits or coma.
Croatian: Ako primite preveliku dozu lijeka Zavicefta, to može utjecati na mozak i uzrokovati napadaje ili komu.
English: What you need to know before you use Zavicefta
Croatian: Što morate znati prije nego počnete primati lijek Zavicefta
English: Introduce the syringe needle through the vial closure and inject 10 mL of sterile water for injections.
Croatian: Uvedite iglu štrcaljke kroz čep bočice i injicirajte 10 ml sterilne vode za injekcije.
English: The pharmacokinetics of both ceftazidime and avibactam are approximately linear across the dose range studied (50 mg to 2000 mg) for a single intravenous administration.
Croatian: Farmakokinetika ceftazidima i avibaktama približno su linearne u ispitivanom rasponu doza (50 mg do 2000 mg) nakon jednokratne intravenske primjene.
English: Lab tests
Croatian: Laboratorijske pretrage
English: Clinical data have demonstrated that there is no interaction between ceftazidime and avibactam, and between ceftazidime/avibactam and metronidazole.
Croatian: Klinički podaci pokazali su da nema interakcije između ceftazidima i avibaktama, kao ni između ceftazidima/avibaktama i metronidazola.
English: Reduced clearance of ceftazidime was observed in elderly patients, which was primarily due to agerelated decrease in renal clearance of ceftazidime.
Croatian: Smanjen klirens ceftazidima primijećen je u starijih bolesnika, što je prvenstveno bila posljedica dobno uvjetovanog smanjenja bubrežnog klirensa ceftazidima.
English: Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity or genotoxicity.
Croatian: Neklinički podaci ne ukazuju na poseban rizik za ljude na temelju konvencionalnih ispitivanja sigurnosne farmakologije, toksičnosti ponovljenih doza ili genotoksičnosti.
English: The reconstituted vial should be used immediately.
Croatian: Rekonstituirani sadržaj bočice mora se odmah primijeniti.
English: How much to use The recommended dose is one vial (2 g of ceftazidime and 0.5 g of avibactam), every 8 hours.
Croatian: Koliko lijeka treba primijeniti Preporučena doza je jedna bočica (2 g ceftazidima i 0,5 g avibaktama) svakih 8 sati.
English: • you have ever had a severe allergic reaction to other antibiotics belonging to the penicillin or carbapenem groups
Croatian: • ako ste ikada imali tešku alergijsku reakciju na neki drugi antibiotik koji pripada skupini penicilina ili karbapenema
English: The reconstituted solution must be further diluted to produce Zavicefta solution for infusion.
Croatian: Rekonstituirana otopina mora se dodatno razrijediti kako bi se dobila otopina lijeka Zavicefta za infuziju.
English: Talk to your doctor or nurse if you suffer from diarrhoea during your treatment.
Croatian: Obavijestite svog liječnika ili medicinsku sestru ako tijekom Vašeg liječenja patite od proljeva.
English: Prolonged use may result in the overgrowth of non-susceptible organisms (e.g. enterococci, fungi), which may require interruption of treatment or other appropriate measures.
Croatian: Dugotrajna primjena može dovesti do prekomjernog rasta neosjetljivih organizama (npr. enterokoka, gljivica), što može zahtijevati privremen prekid liječenja ili provedbu drugih odgovarajućih mjera.
English: Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, reproduction toxicity or genotoxicity.
Croatian: Neklinički podaci ne ukazuju na poseban rizik za ljude na temelju konvencionalnih ispitivanja sigurnosne farmakologije, toksičnosti ponovljenih doza, reproduktivne toksičnosti ili genotoksičnosti.
English: Animal studies with avibactam have shown reproductive toxicity without evidence of teratogenic effects (see section 5.3).
Croatian: Ispitivanja avibaktama na životinjama pokazala su reproduktivnu toksičnost, bez dokazanih teratogenih učinaka (vidjeti dio 5.3).
English: • you are allergic to other cephalosporin antibiotics
Croatian: • ako ste alergični na druge cefalosporinske antibiotike
English: 5-14 days
Croatian: 5 - 14 dana
English: Severe hypersensitivity (e.g. anaphylactic reaction, severe skin reaction) to any other type of β-lactam antibacterial agent (e.g. penicillins, monobactams or carbapenems).
Croatian: Teška preosjetljivost (npr. anafilaktička reakcija, teška kožna reakcija) na bilo koju drugu vrstu beta-laktamskog antibakterijskog lijeka (npr. penicilini, monobaktami ili karbapenemi).
English: No data are available on animal studies with ceftazidime.
Croatian: Nema dostupnih podataka o ispitivanjima ceftazidima na životinjama.